[1] |
Calvopiña M, Montesdeoca-Andrade M, Bastidas-Caldes C, et al. Case report: first report on human infection by tick-borne Babesia bigemina in the Amazon region of Ecuador[J]. Front Public Health, 2023, 11: 1079042.
|
[2] |
Chen MX, Xue JB, Ai L, et al. Epidemic status and research progress of babesiosis in China[J]. J Trop Dis Parasitol, 2022, 20(3): 149-157. (in Chinese)
|
|
(陈木新, 薛靖波, 艾琳, 等. 我国巴贝虫病流行现状与研究进展[J]. 热带病与寄生虫学, 2022, 20(3): 149-157.)
|
[3] |
Ord RL, Lobo CA. Human babesiosis: pathogens, prevalence, diagnosis and treatment[J]. Curr Clin Microbiol Rep, 2015, 2(4): 173-181.
pmid: 26594611
|
[4] |
Akash S, Hosen ME, Mahmood S, et al. Anti-parasitic drug discovery against Babesia microti by natural compounds: an extensive computational drug design approach[J]. Front Cell Infect Microbiol, 2023, 13: 1222913.
|
[5] |
Liu W, Luan Y, Liu XZ. Research progress of Babesia and its transmission through blood transfusion[J]. Chin J Blood Transfus, 2011, 24(4): 355-358. (in Chinese)
|
|
(刘炜, 栾燕, 刘显智. 巴贝虫病及其经输血传播研究进展[J]. 中国输血杂志, 2011, 24(4): 355-358.)
|
[6] |
Bishop A, Wang HH, Grant WE. Using data surveillance to understand the rising incidence of babesiosis in the United States, 2011—2018[J]. Vector Borne Zoonotic Dis, 2021, 21(5): 391-395.
|
[7] |
Marcos LA, Wormser GP. Relapsing babesiosis with molecular evidence of resistance to certain antimicrobials commonly used to treat Babesia microti infections[J]. Open Forum Infect Dis, 2023, 10(8): ofad391.
|
[8] |
Mouhand A, Pissarra J, Delbecq S, et al. 1H, 13C and 15N backbone and side-chain resonance assignments of ∆∆BmSA1, the surface antigen of Babesia microti[J]. Biomol NMR Assign, 2023, 17(2): 217-221.
|
[9] |
Locke S, O’Bryan J, Zubair AS, et al. Neurologic complications of babesiosis, United States, 2011—2021[J]. Emerg Infect Dis, 2023, 29(6): 1127-1135.
doi: 10.3201/eid2906.221890
pmid: 37209667
|
[10] |
Expert Group of National Center for Infectious Diseases. Guidelines for malaria diagnosis and treatment[J]. Chin J Parasitol Parasit Dis, 2022, 40(4): 419-427. (in Chinese)
|
|
(国家传染病医学中心撰写组. 疟疾诊疗指南[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(4): 419-427.)
doi: 10.12140/j.issn.1000-7423.2022.04.001
|
[11] |
Huang L, Sun Y, Huo DD, et al. Successful treatment with doxycycline monotherapy for human infection with Babesia venatorum (Babesiidae, Sporozoa) in China: a case report and proposal for a clinical regimen[J]. Infect Dis Poverty, 2023, 12: 67.
doi: 10.1186/s40249-023-01111-1
pmid: 37443058
|
[12] |
Xu YL, Li JF, Zhang JQ, et al. A case of late stage tumor combined with Babesia infection[J]. Chin J Parasitol Parasit Dis, 2023, 41(3): 393-396. (in Chinese)
|
|
(徐以勒, 李江峰, 张家祺, 等. 晚期癌症患者合并巴贝虫感染1例[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(3): 393-396.)
doi: 10.12140/j.issn.1000-7423.2023.03.021
|